Sun, Sep 26, 2021
OPEN ACCESS
Volume 20, Issue 3 (May - June 2021)                   Payesh 2021, 20(3): 333-345 | Back to browse issues page

Ethics code: IR.YAZD.REC.016/1398


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Torkashvand Moradabadi M, Soroush W, Torkashvand Z. Mortality rate and years of life lost due to cancer in Iran from 2011 to 2018. Payesh. 2021; 20 (3) :333-345
URL: http://payeshjournal.ir/article-1-1630-en.html
1- Faculty of Social Sciences, Yazd University, Yazd, Iran
2- School of Paramedicine, Iran University of Medical Sciences, Tehran
Abstract:   (271 Views)
Objective (s): Cancer is one of the leading causes of death. Cancer is the third leading cause of death in Iran. The goal of this study was to identify the trends in cancer mortality by age and sex in Iran from 2011 to 2018.
Methods: We analyzed cancer mortality data available in the Civil Registration Organization. A total of 278301 cancer deaths were registered in this database during 2011-2018. The rate of cancer deaths was then compared by age, sex, and time.  
Results: The cancer death rate (per 100,000) has increased from 38 in 2011 to 47 in 2017. The mean age of mortality by cancer, death rate, and its increase was higher among men than women. Premature death due to cancer has increased from 420 to 530 thousand person-years of life during 2011 to 2016, respectively. This increase was mainly due to an increase in adulthood cancer and old age, especially among the male gender.
Conclusion: Cancer deaths have increased in Iran since cancer has increased in the country as an epidemiological transition consequence. To overcome such excess mortality preventive measures are recommended.
Full-Text [PDF 884 kb]   (118 Downloads)    
type of study: Research | Subject: Sicial Medicine
Received: 2021/04/22 | Accepted: 2021/05/16 | ePublished ahead of print: 2021/06/28 | Published: 2021/07/3

References
1. M.H. Wahdan. The epidemiological transition. Eastern Mediterranean Health Journal 1996; 2‎: 8-20
2. WHO. Global health estimates 2017 (deaths by cause, age, sex, by country and by region, 2000-2016 and life expectancy, 2000-2016. 1st Edition, WHO: Geneva, 2018
3. Murray, Christopher & Cristiana, Abbafati & Abbas, et al. Five insights from the Global Burden of Disease Study 2019. Lancet 2020; 396: 1135-1159 [DOI:10.1016/S0140-6736(20)31404-5]
4. Kyu HH Abate D Abate KH et al. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392: 1859-1922 [DOI:10.1016/S0140-6736(18)32335-3]
5. Rudd K Johnson S Agesa K et al. Global, regional, and national sepsis incidence and mortality, 1990-2017. Lancet 2020; 395: 200-211 [DOI:10.1016/S0140-6736(19)32989-7]
6. Theo Vos, Stephen S Lim, Cristiana Abbafati, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019. Lancet 2020; 396: 1204-1222 [DOI:10.1016/S0140-6736(20)30925-9]
7. WHO. Noncommunicable diseases. 1st Edition, WHO: Geneva, 2018
8. A. Friedman. Cancer as multifaceted disease. Mathematical Modelling of Natural Phenomena Journal 2012; 7: 3-28 [DOI:10.1051/mmnp/20127102]
9. Rebecca L. Siegel et al. Cancer Society. Cancer Facts & Figures 2021. American Cancer Society Journal 2021: 71: 7-33
10. Stanaway J. Christopher J.L. Murray, Ashkan Afshin. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392:1923-94 [DOI:10.1016/S0140-6736(18)32225-6]
11. C. Fitzmaurice, D. Abate, and N. Abbasi. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017 A Systematic Analysis for the Global Burden of Disease Study, Journal of Clinical Oncology 2019; 12: 1749-1768
12. A. H. Zeinalzadeh, R. Hosseini, and L. Abdullahi. Survey of Epidemiology of Cancers in the Patients above 15 Years Old in East Azerbaijan Province, Iran 2013. Journal of Ardabil University of Medical Sciences 2015; 15: 46-55
13. Torkashvand Moradabadi M, Torkashvand Z. Epidemiological transition and the importance of social policy: mortality statistic in Ilam, Iran during 2011-2017. Payesh 2019; 18: 321-331 [Persian]
14. Naghavi M. Transition in Health Status in the Islamic Republic of Iran. Iranian Journal of Epidemiology 2006; 2: 45-57 [Persian]
15. Torkashvand Moradabadi M, Abbasi M. An Epidemiological study of mortality among elderly in Iran using Years of Life Lost (YLL) index during 2011 to 2017. Payesh 2020; 19: 85-97 [Persian] [DOI:10.29252/payesh.19.1.85]
16. Torkashvand Moradabadi, Mohammad, Sensitivity Analysis and Reexamination of the Techniques for Evaluating Adult Death Registration [On the basis of data of province of Iran], A thesis submitted to the graduate studies for the degree of Ph.D. in demography, Tehran University, 2017: DOI;13140/RG.2.2.34138.29123 [Persian]
17. Torkashvand Moradabadi, M., Falah, H. The Evaluation of the Death Registration Coverage in the Civil Registration Organization of Iran (Case Study of Yazd Province, 2016). Journal of Applied Sociology 2020; 31: 21-34
18. Koosheshi, M. & Torkashvand Moradabadi, M. Investigating the Adaptation of Age Pattern of Mortality in Iran with Model Life Tables. Iranian Population Studies Journal 2018; 3: 39 - 63 [Persian]
19. Shokohmand, M. Investigating the Factors Affecting Late Birth and Death Registration in Ahvaz City, MA Thesis 2010, Islamic Azad University, Shoushtar Branch
20. Zanjani, H. Investigating Mortality in Iran from Census Data. Iranian Journal of Population Studies 1992; 3: 69-78 [Persian]
21. Zanjani, H. Evaluation of Location-Based Vital Event Information Record (Birth, Death and Internal Migration). Research Project, Bureau of Statistics and Population Data, Civil Registration Organization, Tehran 2013 [Persian]
22. M. S. Lima et al. Temporal trend of cancer mortality in a Brazilian state with a medium Human Development Index 1980-2018. Scientific Reports 2020; 10: 1-10 [DOI:10.1038/s41598-020-78381-4]
23. F. K. Shadmani, F. Farzadfar, M. Yoosefi, K. Mansori, R. K. Shadman, and A. Haghdoost. Premature mortality of gastrointestinal cancer in Iran: Trends and projections 2001-2030. BioMed Central Cancer 2020; 20: 1-11 [DOI:10.1186/s12885-020-07132-5]
24. K. L. Yan et al. Rising incidence and incidence-based mortality of thyroid cancer in California, 2000-2017. Journal of Clin. Endocrinol. Metab 2020; 105: 1770-1777 [DOI:10.1210/clinem/dgaa121]
25. L. Ventura et al. Estimates of cancer burden in Tuscany. Tumori Journal 2013; 99: 334-341 [DOI:10.1177/030089161309900308]
26. M. Fusco, R. De Angelis, G. Senatore, G. Zigon, and S. Rossi. Estimates of cancer burden in Campania. Tumori Journal 2013; 99: 374-381 [DOI:10.1177/030089161309900313]
27. S. Rosso et al. Estimates of cancer burden in Piedmont and Aosta Valley. Tumori Journal 2013; 99: 269-276 [DOI:10.1177/030089161309900301]
28. R. Galasso, R. Capocaccia, L. Del Riccio, L. Viviano, R. Matera, and S. Rossi. Estimates of cancer burden in Basilicata and Calabria. Tumori Journal 2013; 99: 390-398 [DOI:10.1177/030089161309900315]
29. fatemeh karimi, R. Entezar Mahdi, and H. R. KHalkhali. Estimation burden of breast cancer in West Azarbaijan province in year 2013. Urmia Medicine Jounal 2017; 28: 1-7
30. Z. Vafaeinezhad et al. Trends in Cervical Cancer Incidence in Iran According to National Cancer Registry. J Maz. University of Medical Sciences 2018; 28: 108-114
31. Hoseini, S et al. Changes in prevalence and epidemiology of female genital cancers in northeastern Iran in a 35-year study. The Iranian Journal of Obstetrics, Gynecology and Infertility 2020; 22: 11-18
32. N. Khaltaev and S. Axelrod. Global lung cancer mortality trends and lifestyle modifications: Preliminary analysis. Chinical Medicine Journal 2020; 133: 1526-1532 [DOI:10.1097/CM9.0000000000000918]
33. A. H. Zeinalzadeh, R. Hosseini, and L. Abdullahi. Survey of Epidemiology of Cancers in the Patients above 15 Years Old in East Azerbaijan Province, Iran 2013. J. Ardabil University Medical Scienesec 2015; 15: 46-55.
34. M. Abbasi, F. Moradi, F. Esna-Ashari, and M. A. Seifrabiei. Epidemiological and Pathological Study of Lung Cancer in Patients Referred to Ekbatan and Shahid Beheshti Hospitals in Hamadan during 2001 - 2016. Avicenna J. Clinimcal Medicine 2019; 25: 236-243 [DOI:10.21859/ajcm.25.4.236]
35. N. Rajai et al. "National and subnational trends in incidence and mortality of lung cancer in Iran from 1990 to 2016. Asia. Pac. J. Clin. Oncol. 2020; 19: 1-8 [DOI:10.1111/ajco.13303]
36. J. S. Torres-Roman et al. Cervical cancer mortality in Peru: regional trend analysis from 2008-2017. BMC Public Health 2021; 21: 1-11 [DOI:10.1186/s12889-021-10274-1]
37. K. Gao and J. Wu. National trend of gastric cancer mortality in China (2003-2015): A population-based study. Cancer Commun 2019; 39: 1-5 [DOI:10.1186/s40880-019-0372-x]
38. W. Zheng et al. Trend analysis of lung cancer mortality and years of life lost (YLL) rate from 1999 to 2016 in Tianjin, China: Does the lung cancer burden in rural areas exceed that of urban areas?. Thorac Cancer 2020; 28: 867-874 [DOI:10.1111/1759-7714.13314]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2021 All Rights Reserved | Payesh (Health Monitor)

Designed & Developed by : Yektaweb